1Verdecchia P,Schillaci G,Reboldi G,et al.Different prognostic impact of24-hour mean blood pressure and pulse pressure on stroke and coronary artery disease in essential hypertension[J].Circulation,2001,103 (21):2579 ～ 2584. 被引量：1
2Duggirala MK,Cuddihy RM,Cuddihy MT,et al.Predictors of blood pressure control in patients with diabetes and hypertension seen in primary care clinics[J].Am J Hypertens.2005,18(6):833 ～ 838. 被引量：1
3Nair GV,Chaput LA,Vittinghoff E,et al.Pulse pressure and cardiovascular events in postmenopausal women with coronary heart disease[J].Chest,2005,127(5):1498 ～ 1506. 被引量：1
4Franklin SS,Larson MG,Khan SA,et al.Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study[J].Circulation,2001,103(9):1245 ～ 1249. 被引量：1
5Safar ME.Epidemiological aspects of pulse pressure and arterial stiffness[J].J Hypertens Suppl,1999,17(5):S37 ～ 40. 被引量：1
6Benetos A,Rudnichi A,Safar M,et al.Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects[J].Hypertension,1998,32(3):560 ～ 564. 被引量：1
7Hansson L,Zanchetti A,Carruthers SG,et al.Effects of intensive bloodpressure lowering and low-dose aspirin in patients with hypertension:principal results of the Hypertension Optimal Treatment (HOT) randomised trial.HOT Study Group[J].Lancet,1998,351(9 118):1755～ 1762. 被引量：1
8Franklin SS.Is there a preferred antihypertensive therapy for isolated systolic hypertension and reduced arterial compliance?[J].Curr Hypertens Rep,2000,2(3):253 ～ 259. 被引量：1
9Kato M,Sada T,Mizuno M,et al.Effect of Combined Treatment With an Angiotensin Ⅱ Receptor Antagonist and an HMG-CoA Reductase Inhibitor on Atherosclerosis in Genetically Hyperlipidemic Rabbits[J].J Cardiovasc Pharmacol,2005,46(4):556 ～ 562. 被引量：1
10Dorval JF,Anderson T,Buithieu J,et al.Reaching recommended lipid and blood pressure targets with amlodipine/atorvastatin combination in patients with coronary heart disease[J].Am J Cardiol,2005,95(2):249 ～ 253. 被引量：1
3ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(Writing Committee to Up-date the 2001 Guidelines for the Evaluation and Management of Heart Failure) [J]. JAMA, 1995, 273(18) :1 450-1 456. 被引量：1
4Karas RH. Statin use is associated with enhanced collateralization of severely diseased coronary arteries [ J ]. Am Heart J, 2003,146 ( 5 ) : 876 - 881. 被引量：1
6Ichiki T, Takeda K, Tokunou N, et al. Downregulation of angiotensin Ⅱ type 1 receptor by hydrephobic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in vascular smooth muscle cells[ J ]. Arterioscler Thromb Vase Boil ,2001,21 (12) : 1 896 - 1 901. 被引量：1
7Thurmann PA,Kenedi P,Schidt A,el al. Influence of the angiotensin Ⅱ antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension[ J]. Circulation, 1998,98(19) :2 037 -2 042. 被引量：1
